Cite
Moser T, Waldispuehl-Geigl J, Belic J, et al. On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer. NPJ Precis Oncol. 2020;4(1):30doi: 10.1038/s41698-020-00134-3.
Moser, T., Waldispuehl-Geigl, J., Belic, J., Weber, S., Zhou, Q., Hasenleithner, S. O., Graf, R., Terzic, J. A., Posch, F., Sill, H., Lax, S., Kashofer, K., Hoefler, G., Schoellnast, H., Heitzer, E., Geigl, J. B., Bauernhofer, T., & Speicher, M. R. (2020). On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer. NPJ precision oncology, 4(1), 30. https://doi.org/10.1038/s41698-020-00134-3
Moser, Tina, et al. "On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer." NPJ precision oncology vol. 4,1 (2020): 30. doi: https://doi.org/10.1038/s41698-020-00134-3
Moser T, Waldispuehl-Geigl J, Belic J, Weber S, Zhou Q, Hasenleithner SO, Graf R, Terzic JA, Posch F, Sill H, Lax S, Kashofer K, Hoefler G, Schoellnast H, Heitzer E, Geigl JB, Bauernhofer T, Speicher MR. On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer. NPJ Precis Oncol. 2020 Nov 13;4(1):30. doi: 10.1038/s41698-020-00134-3. PMID: 33299124; PMCID: PMC7666126.
Copy
Download .nbib